Adjust Text Size:change font sizechange font sizechange font sizechange font sizechange font sizechange font size



PD ExpertBriefing Questions

Technical:  Contact NetBriefings via Online Help, an Email Form or at (651) 225-1532.

About PD (General): Contact PDF at or (800) 457-6676.

About CEUs: Contact ASA at (415) 974-9628 


When Parkinson's Interferes with Gastrointestinal Function

Originally presented on June 24, 2014
Peter A. LeWitt, M.D., Professor of Neurology, Wayne State University School of Medicine and Director, Parkinson’s Disease and Movement Disorder Program, Henry Ford Hospital

Estimates show that up to 80 percent of people with Parkinson’s disease experience issues with their gastrointestinal system, such as bowel dysfunction and constipation. How can these symptoms be managed? Get tips by joining PDF and Dr. LeWitt for a one-hour online seminar on the topic. Online viewers can submit questions in real-time during the second half of the seminar. 

View this PD ExpertBriefing Now

Download Slides (may take several minutes, does not include recording)

Goals for Participants

  • Understand how Parkinson’s affects the gastrointestinal system.
  • Be able to identify some common gastrointestinal issues that people with Parkinson’s disease may experience, such as constipation or difficulty with bowel movements.
  • Learn practical ways to manage these symptoms, including through medication, nutrition and other strategies.


Dr. Peter LeWitt

Peter A. LeWitt, M.D., is Professor of Neurology at Wayne State University School of Medicine. Dr. LeWitt directs the Parkinson’s Disease and Movement Disorder Program at Henry Ford Hospital.

Dr. LeWitt’s research interests include neuroprotection and pharmacological management of Parkinson’s disease and other neurodegenerative conditions. He has been active in clinical trials of new medications for Parkinson’s and Alzheimer’s. He is a steering committee member and investigator for clinical trials conducted by the Parkinson Study Group and a participant in a National Institutes of Health (NIH) research consortium on neuroprotection in Parkinson’s.

Dr. LeWitt is President of the Michigan Parkinson Foundation and President of the International Essential Tremor Foundation and has directed the National Parkinson Foundation’s Center of Excellence in Southfield, Michigan. He has served as an educator for the American Academy of Neurology and The Movement Disorder Society, where he also serves as Secretary. He has been a scientific review consultant for the NIH, the Veterans Administration, and the Michael J. Fox Foundation for Parkinson’s Research. Dr. LeWitt has also served as a consultant to many US and international pharmaceutical firms with respect to drug development and clinical trials in neurological disorders.

He is the author of more than 300 publications on clinical and basic neuroscience and in 1999 edited, Parkinson’s Disease: The Treatment Options. He also serves as Editor-in-Chief of Clinical Neuropharmacology and is a member of the editorial board of Journal of Neural Transmission. Since 1994, he has been listed in “The Best Doctors in America”.

Dr. Lewitt is a Board-certified neurologist sub-specializing in movement disorders. He received his undergraduate and research training and medical degrees from Brown University and received additional post-graduate medical and research training from the University of Pennsylvania School of Medicine, Stanford University School of Medicine and the NIH.

Questions? CEUs?

If you have questions about how to join this PD ExpertBriefing, by phone or online, please see our PD ExpertBriefing FAQ. 

Are you a health care professional seeking continuing education units? CEUs are provided via PDF's sponsorship of the American Society on Aging. The CEU deadline for this online seminar has now passed. Please check our schedule of future seminars for opportunities to obtain continuing education credits.

Other Seminars

Browse our library of past seminars and watch them at any time to learn more about nutrition, the PD pipeline and other topics.

This series has been made possible by educational grants from AbbVie, Inc. and Teva Neuroscience.